Acute Kidney Injury Treatment Market

Acute Kidney Injury Treatment Market Outlook (2022 to 2029)

The global Acute Kidney Injury Treatment Market is expected to witness staggering growth, registering an 8.2% CAGR during the forecast period (2022 to 2029). The overall demand for acute kidney injury treatment is expected to surpass a valuation of USD 2,058.2 Million in 2022 and is projected to reach USD 3,566.7 Million by the end of 2029.

Attribute	Details
Acute Kidney Injury Treatment Market Size Value in 2014	USD 1,177.7 Million
Acute Kidney Injury Treatment Market Size Value in 2029	USD 3,566.7 Million
Acute Kidney Injury Treatment Market Historical CAGR (2014 to 2021)	7.1%
Acute Kidney Injury Treatment Market CAGR (2022 to 2029)	8.2%

The rising incidence of acute kidney injuries and the increasing rate of dialysis therapies are primary factors driving the acute kidney injury treatment market. Besides this, growing awareness regarding the early prognosis of this injury will also fuel the demand for acute kidney injury treatment worldwide.

Regionally, North America is anticipated to account for the largest share of the global acute kidney injury treatment market. As per the study, over 40.8% of acute kidney injury treatment sales are expected to concentrate in North America through 2022.

How The Market Progressed Till June 2022?

Particulars	Details
H1, 2021	8.11%
H1, 2022 Projected	8.17%
H1, 2022 Outlook	6.97%
BPS Change - H1, 2022 (O) - H1, 2022 (P)	(-) 120 ↓
BPS Change - H1, 2022 (O) - H1, 2021	(-) 114 ↓

The H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 120 BPS. In H1-2022, the growth rate of the acute kidney injury treatment market is expected to fall by 114 basis point shares (BPS), as per FMI analysis.

The market shows a decline in the BPS values, owing to the substantial inpatient costs incurred by patients with acute kidney injury (AKI). Moreover, patients with dialysis requirements experience a greater burden associated with healthcare costs due to longer hospitalization.

The substantial difference in pricing for acute kidney injury treatment and care in hospital settings has thus resulted in a drop in the BPS values.

The market is influenced by several macro and industrial dynamics, such as disease prevalence, and target population group demography. The key developments in this market include the advancements in the current understanding of renal injury and repair signaling for better management of AKI.

Conversely, the development of novel biomarkers which aid with the differentiation of AKI from Acute tubular necrosis (ATN), has presented opportunities for enhanced disease diagnosis, identification, and management, thus providing a positive outlook towards market growth.

Download Report Brochure

2014 to 2021 Acute Kidney Injury (AKI) Treatment Market Outlook In Comparison To 2022 to 2029 Forecast

As per Future Market Insights (FMI), the global acute kidney injury treatment market grew at 7.1% CAGR between 2014 and 2021. The demand for acute kidney injury treatment is expected to increase two-fold, exceeding USD 1,897.7 Million through 2021 & beyond.

Advancements in diagnostic technology and growing cases of acute kidney injuries are expected to bolster the growth in the market. With increasing kidney-related disorders across the globe, the number of dialysis centers has surged worldwide.

As the rate of acute kidney injury cases is increasing, patients are actively seeking advanced acute renal disease treatment. On account of this, healthcare professionals are adopting advanced diagnostic equipment to enhance the detection of disease and improve the care of patients.

Besides this, the growing adoption of advanced treatment across emerging economies such as India, Japan, and China is propelling growth in the East and South Asia markets. Backed by these aforementioned factors, the global acute injury treatment market is poised to expand at 8.2% CAGR between 2022 and 2029, surpassing USD 2,237.2 Million by the end of 2023.

Which Are The Key Trends Driving The Acute Kidney Injury Treatment Market?

The advent of Tech-Driven AKI Treatment to Drive the Acute Kidney Injury Treatment Market

According to the International Society of Nephrology (ISN), around 13.3 million people suffer from acute kidney injury (AKI). Among these, nearly 11.3 million cases are from emerging economies such as India, China, Africa, and Japan.

Out of 1.7 million deaths globally every year due to AKI, around 1.4 million occur in low- and middle-income economies. To reduce the global burden of acute renal diseases and kidney injuries, the demand for advanced diagnostic treatment is increasing.

Conventional dialysis systems require manual adjustments for every individual and parameter. However, with the advancements in technology and integration of artificial intelligence in AKI stage 1 treatment, automated dialysis treatment is delivering enhanced care to patients.

These new-age dialysis machines enable all the parameters automatically, minimizing human intervention. Moreover, key players are improving the efficiency of dialysis, including the usage of high-flux and high-efficacy membranes, emanating from technical advances.

This is expected to boost the global acute kidney injury treatment market over the forecast period (2022 to 2029).

What Are The Factors Limiting The Growth In Acute Kidney Injury Treatment Market?

High-Cost Associated with AKI Treatment Equipment Might Impede the Sales

While new product development and the introduction of portable, automated AKI equipment favoring growth in developed economies, high-cost associated with this equipment might impede sales in low-income countries.

Besides this, the lack of early disease detection and awareness regarding kidney-related diseases and acute kidney injuries in emerging economies will also hamper the growth of the market.

However, governments in countries such as India and China are introducing reimbursement policies to offer treatment at a low cost. Some private healthcare organizations are also undertaking several initiatives and projects to increase awareness regarding AKI.

This is expected to aid the growth of the acute kidney injury treatment market, especially across the Asia Pacific and Latin America.

Country-Wise Analysis

Which are the Factors Driving the USA Acute Kidney Injury Treatment Market?

Rising Awareness for Acute Renal Disease Treatment to Augment Growth

As per Future Market Insights, North America is expected to dominate the market, with the USA leading the growth in North America. Primary factors underpinning the growth in the market include the rising prevalence of kidney-related disorders and rapid development in diagnostic equipment.

According to the research, nearly 786,000 people are living with kidney-related disorders in the USA Among 1000 persons 55 of them are hospitalized with severe acute kidney injury diagnoses. Out of which 5% succumb to the disease every year, states medical research in the USA

With rising awareness regarding acute renal disease treatment, the development of advanced and automated AKI diagnostic equipment is surging in the USA Several private healthcare organizations are increasing the adoption of advanced AKI equipment to enhance the care to the patients.

On account of this, several leading players are eyeing the USA market to increase their revenue through product development and new launches in the country. A slew of such developments by key players are expected to bolster the growth in the USA market.

What is the India Acute Kidney Injury Treatment Market Outlook?

Surging Prevalence of AKI to Increase the Demand for Acute Kidney Diseases Treatment

According to the ISN, nearly 1.4 million succumb to acute kidney injuries in low and middle-income countries, among which the majority of the cases are recorded in India. Due to the rising prevalence of AKI, the number of dialysis centers has surged in the country.

With the establishment of these centers, the adoption of AKI treatment equipment is increasing among healthcare professionals. Additionally, rapid technological advancements in healthcare infrastructure and favorable government policies are also improving the adoption of advanced AKI equipment and diagnostic treatment.

Also, increasing awareness regarding the treatment for acute kidney disease is expected to boost the sales of AKI treatment diagnostic equipment in these dialysis centers. Subsequently, rising disposable income and growing health consciousness have enabled patients to opt for advanced treatment for these diseases.

Backed by these aforementioned factors, key players aiming for novel product development and launches in India. This is expected to create a conducive environment for the acute kidney injury treatment market in India.

Will the Demand for Acute Kidney Injury Treatment in China Increase?

Influenced by Well-Established Healthcare Infrastructure, China AKI Treatment Market is Set to Gain Traction

China is one of the fastest-growing markets for acute kidney injury treatment. Growth in the country is attributable to the rising incidence of kidney-related diseases and the expansion of the healthcare industry.

With the growing prevalence of pre-renal injuries in China, the rate of hospitalization, especially for the geriatric population has increased. Hence, the adoption of dialysis equipment and drug-induced therapies has surged in China’s healthcare industry.

Also, the government in China is adopting various initiatives and introducing projects to create awareness regarding AKI and kidney-related diseases.

For instance, in 2017, China’s central government issued the 13th Five-Year National Science and Technology Innovation Plan, which aims to create a national platform to share biomedical big data

The expansion of the healthcare industry and the adoption of automated diagnostic equipment is favoring the growth in the China market. On the back of developing the healthcare industry, key players are streamlining their projects and introducing new products in China.

Such factors are projected to propel the growth in China's acute kidney injury treatment market over the forecast period.

Category-Wise Insights

Which Product Type is More Preferred in the Acute Kidney Injury Treatment Market?

Dialysis and Pre-Renal Injury to Account for Maximum Share in Acute Kidney Injury Treatment Market

In terms of product type, the dialysis segment is expected to account for the maximum revenue share during the forecast period. With the growing prevalence of acute kidney injury, the establishment of dialysis centers across the globe has increased.

As per Future Market Insights, dialysis is expected to remain the most preferred and efficient treatment for AKI. Around 9 out of 10 healthcare professionals suggest and opt for dialysis. As intermittent hemodialysis has excellent efficiency, patients are actively seeking this treatment.

Consequently, governments in emerging economies are establishing an increasing number of dialysis centers. Besides this, the growing prevalence of pre-renal injury is also aiding the growth of the dialysis segment.

In terms of injury type, the pre-renal injury segment is expected to contribute over 60.7% of sales in the acute kidney injury treatment market, as it covers the maximum patient population.

Which is the Preferred Distribution Channel in Acute Kidney Injury Treatment Market?

Hospitals to Contribute over 50% of Global Acute Kidney Injury Treatment Market Sales

In terms of distribution channels, hospitals are expected to gain the maximum share of the acute kidney injury treatment market. According to FMI, over 80% of sales in the market are contributed by hospitals and ambulatory surgical centers, collectively.

However, with well-established infrastructure and the availability of diagnostic equipment in hospitals, governments in several countries are increasing the supply of AKI treatment equipment in hospitals.

Hospitals in several low and middle-income countries are receiving equipment under the initiative of developing healthcare infrastructure by the government and private organizations.

For instance, according to the India Brand Equity Foundation, in 2021, the Ministry of AYUSH was allocated USD 407.84 million to develop the healthcare infrastructure. By 2025, with favorable investment Government of India is planning to increase public health spending by 2.5% of the country’s GDP.

Competitive Landscape

Leading players in the global acute kidney injury treatment market are focusing on developing automated, portable, and tech-driven dialysis equipment to deliver advanced care to patients. They are also integrating advanced technologies such as artificial intelligence and the Internet of Things (IoT) to expand their product portfolio.

Meanwhile, some of the other players are making advancements in diagnostic technology in order to streamline their product offerings in emerging economies with diverse product portfolios.

For instance:

• In March 2021, C-Path announced the launch of an acute kidney injury project in partnership with the USA Food and Drug Administration (FDA) for Drug Evaluation and Research, the Office of translational science, and the Division of cardiology and Nephrology, to develop a suite of prognostic tools to improve the detection of drug-induced kidney injury.
• In June 2021, Abionyxx announced the enrollment of the first patient in its Phase-2a clinical study with CER-001 for the treatment of septic patients at high risk of developing acute kidney injury.

Scope Of Report

Attribute	Details
Forecast Period	2022 to 2029
Historical Data Available for	2014 to 2021
Market Analysis	USD Million for Value
Key Regions Covered	North America; Latin America; Europe; East Asia; South Asia; Oceania; and Middle East and Africa(MEA)
Key Countries Covered	USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, and others.
Key Market Segments Covered	Product, Injury, Distribution Channel, and Region
Key Companies Profiled	Novartis, Pfizer Inc.; Merck & Co.; Biocon Ltd.; Teva Pharmaceutical Industries Ltd.; Mylan Pharmaceuticals Inc.; NIPRO Medical; Baxter Corporation; Asahi Kasei; NIKKISO; Fresenius Medical Care; Others
Pricing	Available upon Request

Acute Kidney Injury Treatment Market By Category

Product:

• Dialysis
  • Intermittent Hemodialysis
  • Continuous Renal Replacement Therapy (CRRT)
  • Sustained Low-Efficiency Dialysis (SLED)
• Drug Therapy
  • Antibiotics
  • Diuretics
  • Immunosuppressive Agents

Injury:

• Pre-renal Injury
• Intrinsic Renal Injury
• Post-renal Injury

Distribution Channel:

• Hospitals
• Ambulatory Surgical Centers
• Others

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa(MEA)